Approval for atopic dermatitis treatment
FDA Breakthrough Therapy Designation for Glanzmann Thrombasthenia drug
New company targets dry eye disease with first-in-class therapy
Collaboration to advance novel combination therapy for glioblastoma
Base to Base biotech podcast 37: Life Sciences in Flanders, AI and drug discovery, and healthcare investment
Faster and more reliable dementia diagnosis
Base to Base biotech podcast 36: Gothenburg, Charcot-Marie-Tooth disease and Ultrasound AI
SAS Clinical Acceleration debuts to modernise clinical trials and accelerate time to market
China’s first AI drug completes phase III trial
Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?
Ryght AI and Biorasi to partner on AI
Novel gene therapy for ALS cleared for trials in US and China